Bioceros BV, of Utrecht, The Netherlands, named Bram Bout chief executive officer.
Confirma Inc., of Bellevue, Wa., appointed Nick Dykstra chief financial officer.
Cougar Biotechnology Inc., of Los Angeles, named Thomas R. Malley to its board of directors.
Epidauros Biotechnologie AG, of Bernreid, Germany, appointed Dagmar Kasper vice president of business development and marketing and Elke Roschmann head of strategic development and licensing.
Isolagen Inc., of Exton, Pa., named Declan Daly chief operating officer.
Living Cell Technologies Ltd., of Melbourne, Australia, appointed Robert J. Beckman, Allan R. Goldberg and Philip N. Sussman to the board of directors of its U.S. subsidiary, LCT BioPharma Inc., of New York.
MedImmune Inc., of Gaithersburg, Md., named William K. Wang director of research and development.
MediQuest Therapeutics Inc., of Bothell, Wa., appointed Steve Murdock senior vice president of sales.
NicOx SA, of Sophia Antipolis, France, named Pascal Pfister chief scientific officer.
Novavax Inc., of Rockville, Md., appointed Len Stigliano vice president, chief financial officer and treasurer.
NPS Pharmaceuticals Inc., of Parsippany, N.J., promoted Francois Nader to executive vice president and chief operating officer.
Symyx Technologies Inc., of San Francisco, named Gerard Abraham president of Symyx Tools.
The Macroflux Corp., of Mountain View, Calif., named Gregory S. Yedinak vice president of manufacturing operations.
Theravance Inc., of South San Francisco, named Burton Malkiel to its board of directors.
ViaCell Inc., of Cambridge, Mass., appointed John F. Thero senior vice president of finance and chief financial officer.
ZymoGenetics Inc., of Seattle, named Douglas E. Williams president of the company and promoted James A. Johnson to executive vice president. The company also appointed Darren R. Hamby senior vice president of human resources.